Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Aspire Pharma Ltd, Unit 4, Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, United Kingdom
Cetraxal 2 mg/ml ear drops solution in single-dose container.
| Pharmaceutical Form |
|---|
|
Ear drops solution in single-dose container. Clear, sterile, preservative-free aqueous solution. |
1 ml solution contains 2 mg of ciprofloxacin as hydrochloride.
Each single-dose ampoule delivers 0.25 ml of solution that contains 0.58 mg of ciprofloxacin hydrochloride monohydrate corresponding to 0.50 mg of ciprofloxacin.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ciprofloxacin |
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Povidone-K-90-F (E1201) |
The solution 0.2% is contained within a formed low-density polyethylene (LDPE) ampoule. Each single ampoule delivers 0.25 ml dropwise. The ampoules are contained in an aluminium foil overwrap pouch for protection.
Each pack contains 15 ampoules.
Aspire Pharma Ltd, Unit 4, Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, United Kingdom
PL35533/0130
30/09/2015
| Drug | Countries | |
|---|---|---|
| CETRAXAL | Ecuador, Spain, Finland, Israel, Poland, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
